Terms ending in 2029
Every in-force patent on Aclarion, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,825,131 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Medium confidence | Aclarion, Inc. | In force | Medium confidence | |
| US 9,392,959 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Medium confidence | Aclarion, Inc. | In force | Medium confidence | |
| US 9,724,013 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Low confidence | Aclarion, Inc. | In force | Low confidence | |
| US 10,251,578 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Medium confidence | Aclarion, Inc. | In force | Medium confidence | |
| US 10,285,622 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Medium confidence | Aclarion, Inc. | In force | Medium confidence | |
| US 11,844,601 | MR Spectroscopy System and Method for Diagnosing Painful and Non-Painful Intervertebral Discs In force · Low confidence | Aclarion, Inc. | In force | Low confidence | |
| US 12,369,813 | MR Spectroscopy System and Method In force · Low confidence | Aclarion, Inc. | In force | Low confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.